PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0010068|coronary heart disease |
| Sentences | 18 |
| PubMedID- 21636030 | We also discuss that a healthy lifestyle is essential for preventing and treating chronic kidney disease and coronary heart disease seen in patients with metabolic syndrome. |
| PubMedID- 22906266 | Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status. |
| PubMedID- 21186101 | Metabolic syndrome was strongly associated with coronary heart disease (or = 4.03; 95% ci: 2.98, 5.45) and the risk seemed to be fully explained by metabolic syndrome components (or = 0.84, p = 0.54 after adjustment). |
| PubMedID- 20826918 | The aim of the present study was to determine the associations between platelet morphology markers and hemoglobin a1c (hba(1c)), fasting glucose (fg), hypertension and coronary heart disease (chd) in patients with myelodysplastic syndromes (mds) and dm, in patients with dm and in controls. |
| PubMedID- 22548293 | Metabolic syndrome is associated with coronary heart disease (chd) and new-onset diabetes after kidney transplant (nodat). |
| PubMedID- 19969373 | Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the heart and soul study. |
| PubMedID- 24793349 | Background and objectives: to evaluate the risk of coronary heart disease (chd) associated with metabolic syndrome (mets) and its individual components in a representative sample of diabetic and nondiabetic iranians. |
| PubMedID- 23479983 | [quality of life in patients with coronary heart disease associated with metabolic syndrome: results of factor analysis]. |
| PubMedID- 23251156 | The increased risk of coronary heart disease in patients with the metabolic syndrome suggests that the insulin-resistant state is atherogenic without concomitant elevations in plasma glucose and glycosylated hemoglobin [26, 27]. |
| PubMedID- 21153653 | Obesity does not appear to be an independent predictor for the 10-year risk of coronary heart disease events in patients without metabolic syndrome treated with second-generation antipsychotics. |
| PubMedID- 26401840 | Correction: the relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function - an occupational cohort-based study. |
| PubMedID- 23091851 | Aim: to define the pharmacogenetic features of the effect of metformin in coronary heart disease (chd) patients with metabolic syndrome (ms) or type 2 diabetes mellitus (t2dm), by taking into consideration ppar-gamma2 pro1 2ala polymorphism. |
| PubMedID- 25018941 | The increased risk of coronary heart disease associated with nephrotic syndrome. |
| PubMedID- 21139493 | Procollagen iii n-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome. |
| PubMedID- 21148595 | Dual role of physical workload and occupational noise in the association of the metabolic syndrome with risk of coronary heart disease: findings from the helsinki heart study. |
| PubMedID- 19935427 | The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. |
| PubMedID- 26274823 | The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function--an occupational cohort-based study. |
| PubMedID- 23819342 | [comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome]. |
Page: 1